Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 158-163

  Nichols Jr , Romaine C ^a   Huh, Soon N ^a   Prado, Karl L ^b   Yi, Byong Y ^b   Sharma, Navesh K ^b   Ho, Meng W ^a   Hoppe, Bradford S ^a   Mendenhall, Nancy P ^a   Li, Zuofeng ^a   Regine, William F ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Dosimetry; Intensity modulated radiotherapy; Pancreatic head cancer; Proton therapy

Indexed keywords

CHEMORADIATION; DOSE DISTRIBUTIONS; INTENSITY-MODULATED RADIOTHERAPY; NORMAL TISSUE CONSTRAINTS; PANCREATIC HEAD; PLANNING TARGET VOLUMES; POSTOPERATIVE RADIOTHERAPY; PROTON THERAPY; RADIATION THERAPY ONCOLOGY GROUPS; SMALL BOWEL; SPINAL CORDS; TREATMENT PLANNING;

DISEASES; DOSIMETRY; OPTIMIZATION; PROTONS; RADIOTHERAPY; TISSUE;

PHYSICAL THERAPY;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY; LIVER; PANCREAS CANCER; PANCREATIC HEAD CANCER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION EXPOSURE; SMALL INTESTINE; SPINAL CORD; TREATMENT OUTCOME; TREATMENT PLANNING;

HUMANS; INTESTINE, SMALL; KIDNEY; LIVER; ORGANS AT RISK; PANCREATIC NEOPLASMS; PROTONS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; SPINAL CORD; STOMACH;

EID: 84862807263     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.045     Document Type: Article

References (19)

1. J. Tepper, G. Nardi, and H. Sutt Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy Cancer 37 1976 1519 1524
2. B. Gudjonsson Cancer of the pancreas. 50 years of surgery Cancer 60 1987 2284 2303
3. W.F. Regine, K.A. Winter, and R.A. Abrams Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA 299 2008 1019 1026
4. J.P. Neoptolemos, J.A. Dunn, and D.D. Stocken Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial Lancet 358 2001 1576 1585
5. J.P. Neoptolemos, D.D. Stocken, and H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
6. R.A. Abrams, K.D. Lillemoe, and S. Piantadosi Continuing controversy over adjuvant therapy of pancreatic cancer Lancet 358 2001 1565 1566
7. S. Yovino, M. Poppe, and S. Jabbour Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers Int J Radiat Oncol Biol Phys 2010
8. Regine WF. Personal communication. October 2010.
9. M. Bouchard, R.A. Amos, and T.M. Briere Dose escalation with proton or photon radiation treatment for pancreatic cancer Radiother Oncol 92 2009 238 243
10. D.C. Hsiung-Stripp, J. McDonough, and H.M. Masters Comparative treatment planning between proton and X-ray therapy in pancreatic cancer Med Dosim 26 2001 255 259
11. K.R. Kozak, L.A. Kachnic, and J. Adams Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment Int J Radiat Oncol Biol Phys 68 2007 1557 1566
12. W.F. Regine Postoperative adjuvant therapy: Past, present, and future trial development Pancreatic Cancer 2002 235 242
13. R.J. Geer, and M.F. Brennan Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 1993 68 72
14. J.E. Lim, M.W. Chien, and C.C. Earle Prognostic factors following curative resection for pancreatic adenocarcinoma: A population-based, linked database analysis of 396 patients Ann Surg 237 2003 74 85
15. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer: Adjuvant combined radiation chemotherapy following curative resection Arch Surg 120 1985 899 903
16. J.H. Klinkenbijl, J. Jeekel, and T. Sahmoud Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 1999 776 782
17. T.S. Hong, D.P. Ryan, and L.S. Blaszkowsky Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head Int J Radiat Oncol Biol Phys 79 2011 151 157
18. A. Gunnlaugsson, E. Kjellen, and P. Nilsson Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer Acta Oncol 46 2007 937 944
19. J.M. Robertson, D. Lockman, and D. Yan The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 70 2008 413 418